Cargando…
Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning?
This letter reflects on the PALOMA‐3 study, as related to the safety analysis of premenopausal breast cancer patients.
Autor principal: | Altundag, Kadri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469593/ https://www.ncbi.nlm.nih.gov/pubmed/28611237 http://dx.doi.org/10.1634/theoncologist.2016-0446 |
Ejemplares similares
-
Addition of granulocyte-colony stimulating factor (G-CSF) may further increase chemosensitive state in premenopausal node-positive breast cancer patients with induced angiogenesis after surgery
por: Altundag, Kadri, et al.
Publicado: (2004) -
Anti IH: An antibody worth mention
por: Mohanan, Nithya, et al.
Publicado: (2016) -
Debut century in cardiac surgery - Is it worth mentioning
por: Javangula, Kalyana
Publicado: (2015) -
Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'
por: Altundag, Kadri
Publicado: (2017) -
Early Mention of the Term Epidemiology
por: Tuells, José
Publicado: (2016)